Upload Image (Max 20MB per Image)
US-based clinical development firm AltheRx Pharmaceuticals has received a notice of allowance for its patent application from the US Patent and Trademark Office (USPTO) for the use of solabegron in combination with antimuscarinics at both ...
Tags: Solabegron Combination Therapy, Oab Patients